Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.

par Berruti, A., Piovesan, A., Torta, M., Raucci, C. A., Gorzegno, G., Paccotti, P., Dogliotti, L., Angeli, A.
Publié 1996

Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience

par Berruti, A, Borasio, P, Gerbino, A, Gorzegno, G, Moschini, T, Tampellini, M, Ardissone, F, Brizzi, M P, Dolcetti, A, Dogliotti, L
Publié 1999

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

par Bottini, A, Berruti, A, Brizzi, M P, Bersiga, A, Generali, D, Allevi, G, Aguggini, S, Bolsi, G, Bonardi, S, Bertoli, G, Alquati, P, Dogliotti, L
Publié 2003

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.

par Tampellini, M., Berruti, A., Gerbino, A., Buniva, T., Torta, M., Gorzegno, G., Faggiuolo, R., Cannone, R., Farris, A., Destefanis, M., Moro, G., Deltetto, F., Dogliotti, L.
Publié 1997

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease

par Berruti, A, Tucci, M, Mosca, A, Tarabuzzi, R, Gorzegno, G, Terrone, C, Vana, F, Lamanna, G, Tampellini, M, Porpiglia, F, Angeli, A, Scarpa, R M, Dogliotti, L
Publié 2005

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

par Bottini, A, Berruti, A, Bersiga, A, Brizzi, M P, Bruzzi, P, Aguggini, S, Brunelli, A, Bolsi, G, Allevi, G, Generali, D, Betri, E, Bertoli, G, Alquati, P, Dogliotti, L
Publié 2001

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases

par Generali, D, Dovio, A, Tampellini, M, Tucci, M, Tedoldi, S, Torta, M, Bonardi, S, Allevi, G, Aguggini, S, Milani, M, Harris, A L, Bottini, A, Dogliotti, L, Angeli, A, Berruti, A
Publié 2008

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients

par Tampellini, M, Saini, A, Alabiso, I, Bitossi, R, Brizzi, M P, Sculli, C M, Berruti, A, Gorzegno, G, Magnino, A, Sperti, E, Miraglia, S, Forti, L, Alabiso, O, Aglietta, M, Harris, A, Dogliotti, L
Publié 2006

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

par Allevi, G, Strina, C, Andreis, D, Zanoni, V, Bazzola, L, Bonardi, S, Foroni, C, Milani, M, Cappelletti, M R, Gussago, F, Aguggini, S, Giardini, R, Martinotti, M, Fox, S B, Harris, A L, Bottini, A, Berruti, A, Generali, D
Publié 2013

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines

par Berruti, A, Bitossi, R, Gorzegno, G, Bottini, A, Generali, D, Milani, M, Katsaros, D, Rigault de la Longrais, I A, Bellino, R, Donadio, M, Ardine, M, Bertetto, O, Danese, S, Sarobba, M G, Farris, A, Lorusso, V, Dogliotti, L
Publié 2005

1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic

par Gurizzan, C., Pedersini, R., Fornaro, C., Sardini, C., Zamparini, M., Monteverdi, S., Tovazzi, V., Cosentini, D., Dalla Volta, A., Baggi, A., Turla, A., Di Mauro, P., Lorini, L., Laganà, M., Bianchi, S., Intagliata, S., Consoli, F., Conti, E., Bossi, P., Berruti, A.
Publié dans Ann Oncol (2020)

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2

par Caffo, O., Zagonel, V., Baldessari, C., Berruti, A., Bortolus, R., Buti, S., Ceresoli, G.L., Donini, M., Ermacora, P., Fornarini, G., Fratino, L., Masini, C., Massari, F., Mosca, A., Mucciarini, C., Procopio, G., Tucci, M., Verri, E., Zucali, P., Buttigliero, C.
Publié dans Ann Oncol (2020)

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer

par Bazzola, L, Foroni, C, Andreis, D, Zanoni, V, R Cappelletti, M, Allevi, G, Aguggini, S, Strina, C, Milani, M, Venturini, S, Ferrozzi, F, Giardini, R, Bertoni, R, Turley, H, Gatter, K, Petronini, P G, Fox, S B, Harris, A L, Martinotti, M, Berruti, A, Bottini, A, Reynolds, A R, Generali, D
Publié dans Br J Cancer (2015)

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

par Casali, P. G., Bruzzi, P., Bogaerts, J., Blay, J.-Y., Aapro, M., Adamous, A., Berruti, A., Blay, J.-Y., Bogaerts, J., Bressington, J., Bruzzi, B., Capocaccia, R., Cardoso, F., Casali, P. G., Celis, J. E., Cervantes, A., Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., De Boltz, D., De Lorenzo, F., Dei Tos, A. P., Gatta, G., Geissler, J., Giuliani, R., Grande, E., Gronchi, A., Jezdic, S., Jonsson, B., Jost, L., Keulen, H., Lacombe, D., Lamory, G., Le Cam, Y., Leto di Priolo, S., Licitra, L., Macchia, F., Margulies, A., Marreaud, S., McVie, G., Narbutas, S., Oliver, K., Pavlidis, N., Pelouchova, J., Pentheroudakis, G., Piccart, M., Pierotti, M. A., Pravettoni, G., Redmond, K., Riegman, P., Ruffilli, M. P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V., Trama, A., Van Belle, S., Vassal, G., Wartenberg, M., Watts, C., Wilson, A., Yared, W.
Publié dans Ann Oncol (2015)